Artelo biosciences to present at the ld micro invitational xii on june 7th

Solana beach, calif., june 01, 2022 (globe newswire) --   artelo biosciences, inc. “artelo” or the “company”) (nasdaq: artl), a clinical-stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that gregory d. gorgas, chief executive officer of artelo, will be presenting at the ld micro conference which is being held on june 7– 9, 2022, at the four seasons westlake village, california.
ARTL Ratings Summary
ARTL Quant Ranking